Navigation Links
Boston Scientific to Participate in Piper Jaffray Health Care Conference
Date:11/24/2008

NATICK, Mass., Nov. 24 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, which is being held December 2 - 3 in New York City.

Jim Tobin, Chief Executive Officer, will make a 30-minute presentation on Tuesday, December 2, beginning at approximately 8:00 a.m. E.T.

A live webcast of Mr. Tobin's remarks will be available to all interested parties at Boston Scientific's website at www.bostonscientific.com. Please visit the website for details on how to access the webcast. To ensure a timely connection to the webcast it is recommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by Piper Jaffray. The replay will be archived and available in the Investor Relations site at www.bostonscientific.com by 10:00 a.m. E.T. on December 2.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.


    CONTACT: Paul Donovan
             508-650-8541 (office)
             508-667-5165 (mobile)
             Media Relations
             Boston Scientific Corporation

             Larry Neumann
             508-650-8696 (office)
             Investor Relations
             Boston Scientific Corporation

'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory
2. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
3. FDA Approves Boston Scientifics Apex(TM) PTCA Dilatation Catheter
4. InterMune to Present at Deutsche Bank Biotech Boston Confab
5. Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability
6. Boston Scientific Announces Results for Third Quarter Ended September 30, 2008
7. Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet
8. Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
9. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
10. Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
11. Boston Scientific to Participate in UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... July 1, 2015   Neuraltus Pharmaceuticals, Inc. ... of groundbreaking drugs to treat neurodegenerative diseases such ... Robert G. Miller , M.D., Director of the ... California Pacific Medical Center in San Francisco, has been ... $1.5 million to help fund a Phase 2 ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan contest will ask ... to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will ... and a period of expert mentorship from a senior industry figure drawn from the ...
(Date:7/1/2015)... ... 2015 , ... NEMA 4 (IP66) Medical Joysticks can be ... have an impermeable molecular barrier protection against bio-hazardous agents. Original Equipment Manufacturers ... healthcare worker safety and reduce financial costs. , CTI Electronics announces a new ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... 12 to take part in the first half of “Integrative Biotechnology,” an applied ... partnership established in summer 2014, this course combines students from both universities and ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
... AMSTERDAM, December 15, 2011 Amsterdam Molecular Therapeutics ... therapy, announced today that the Company has a negative equity ... of this negative equity position is in line with previous ... is exploring alternatives for additional financing. AMT announced ...
... discovery of a new way to tune and enhance thermal ... for a given material gives engineers a new tool ... and a number of other powered devices. The finding ... Li, associate professor of mechanical engineering at Vanderbilt University, and ...
... SHANGHAI, Dec. 14, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... leading China-based pharmaceutical and biotechnology research and development outsourcing ... Morgan,s 30th Annual Healthcare Conference, to be held in ... Michael Xin Hui, founder and Chief Executive Officer of ...
Cached Biology Technology:Amsterdam Molecular Therapeutics Announces Negative Equity Position 2Amsterdam Molecular Therapeutics Announces Negative Equity Position 3New method for enhancing thermal conductivity could cool computer chips, lasers and other devices 2New method for enhancing thermal conductivity could cool computer chips, lasers and other devices 3
(Date:6/30/2015)... 30, 2015 To bolster its efforts and commitment ... announced today the addition of two new team members. ... advisor and David Raviv will act as head ... Corp.,s commitment to providing the most secure solutions for the ... co-founded Layer 7 Technologies, a provider of security and management ...
(Date:6/30/2015)... 30, 2015 Genisphere announced ... to help further develop Genisphere,s therapeutics capabilities and portfolio. ... having spent much of the last 25 years in ... Bioscience, and Johnson & Johnson. Tom started his career ... Biotech Corporate Finance. He graduated from Dartmouth College with ...
(Date:6/29/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ) ... Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... America Biomedical Sensors market is estimated at $0.65 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Latin America Biomedical Sensors Market Report 2015-2020 2
... French . , Chicken sold in supermarkets, restaurants ... urinary tract infections (UTI), McGill researcher Amee Manges has discovered. ... in collaboration with the Public Health Agency of Canada and ... E. coli ( Escherichia coli ) bacteria originating from ...
... the first evidence from human research that blueberries ... other so-called phytochemicals improve memory. They said the ... to determine whether blueberries really deserve their growing reputation ... appears in ACS, Journal of Agricultural and Food ...
... a jury could decide a man,s guilt through mind reading? ... And what constitutes ,intent, to commit murder? These are ... inaugural issue of WIREs Cognitive Science, the latest interdisciplinary project ... the first two years. In the article "Neurolaw," ...
Cached Biology News:Retail meat linked to urinary tract infections: Strong new evidence 2Mind reading, brain fingerprinting and the law 2
... The nature of proteomics demands the ... The superior performance of the AXIMA-CFRplus with ... than 5 ppm) provides increased confidence in ... blanking for enhanced sensitivity, automated sample target ...
... Axima range, the AXIMA-CFR provides a ... sensitivity and mass range, and offers ... reflectron time-of-flight analysis. The unique patented ... of seamless PSD, providing efficient and ...
Rat Lung Fibroblasts (RLF) (>500,000 cells)...
...
Biology Products: